文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[Predicting cerebral glioma enhancement pattern using a machine learning-based magnetic resonance imaging radiomics model].

作者信息

He H, Guo E, Meng W, Wang Y, Wang W, He W, Wu Y, Yang W

机构信息

Nanfang Hospital/First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.

Medical Imaging Center, Guangdong 999 Brain Hospital, Guangzhou 510515, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jan 20;44(1):194-200. doi: 10.12122/j.issn.1673-4254.2024.01.23.


DOI:10.12122/j.issn.1673-4254.2024.01.23
PMID:38293992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10878898/
Abstract

OBJECTIVE: To establish a machine learning radiomics model that can accurately predict MRI enhancement patterns of glioma based on T2 fluid attenuated inversion recovery (T2-FLAIR) images for optimizing the workflow of magnetic resonance imaging (MRI) examinations of glioma patients. METHODS: We retrospectively collected preoperative MR T2-FLAIR images from 385 patients with pathologically confirmed glioma, who were divided into enhancing and non-enhancing groups according to the enhancement pattern. Predictive radiomics models were established using Gaussian Process, Linear Regression, Linear Regression-Least absolute shrinkage and selection operator, Support Vector Machine, Linear Discriminant Analysis or Naive Bayes as the classifiers in the training cohort (=201)and tested both in the internal (=85) and external validation cohorts (=99). The receiver-operating characteristic curve was used to assess the predictive performance of the models. RESULTS: The predictive model constructed based on 15 radiomics features using Gaussian Process as the classifier had the best predictive performance in both the training cohort and the internal validation cohort, with areas under the curve (AUC) of 0.88 (95% : 0.81-0.94) and 0.80 (95% : 0.71-0.88), respectively. In the external validation cohort, the model showed an AUC of 0.81 (95% : 0.71-0.90) with sensitivity, specificity, positive predictive value and negative predictive value of 0.98, 0.61, 0.76 and 0.96, respectively. CONCLUSION: The T2-FLAIR-based machine learning radiomics model can accurately predict the enhancement pattern of gliomas on MRI.

摘要

相似文献

[1]
[Predicting cerebral glioma enhancement pattern using a machine learning-based magnetic resonance imaging radiomics model].

Nan Fang Yi Ke Da Xue Xue Bao. 2024-1-20

[2]
Prediction of Glioma enhancement pattern using a MRI radiomics-based model.

Medicine (Baltimore). 2024-9-6

[3]
T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.

Clin Radiol. 2024-5

[4]
Machine learning-based multiparametric magnetic resonance imaging radiomics model for distinguishing central neurocytoma from glioma of lateral ventricle.

Eur Radiol. 2023-6

[5]
Machine-Learning and Radiomics-Based Preoperative Prediction of Ki-67 Expression in Glioma Using MRI Data.

Acad Radiol. 2024-8

[6]
Predicting Histopathological Grading of Adult Gliomas Based On Preoperative Conventional Multimodal MRI Radiomics: A Machine Learning Model.

Brain Sci. 2023-6-5

[7]
Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.

Korean J Radiol. 2019-9

[8]
An investigation of machine learning methods in delta-radiomics feature analysis.

PLoS One. 2019-12-13

[9]
Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.

BMC Cancer. 2024-4-5

[10]
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.

Eur Radiol. 2019-12-11

本文引用的文献

[1]
The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.

Acta Neurochir (Wien). 2022-8

[2]
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.

Lancet Digit Health. 2021-12

[3]
Evidence-based recommendations on categories for extent of resection in diffuse glioma.

Eur J Cancer. 2021-5

[4]
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

Nat Rev Clin Oncol. 2021-3

[5]
The Role of Imaging Biomarkers Derived From Advanced Imaging and Radiomics in the Management of Brain Tumors.

Front Oncol. 2020-9-23

[6]
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.

Am J Kidney Dis. 2021-4

[7]
FeAture Explorer (FAE): A tool for developing and comparing radiomics models.

PLoS One. 2020-8-17

[8]
Tripartite-GAN: Synthesizing liver contrast-enhanced MRI to improve tumor detection.

Med Image Anal. 2020-7

[9]
Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Neuro Oncol. 2020-3-5

[10]
Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging-a comprehensive overview.

Insights Imaging. 2019-8-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索